4//SEC Filing
Conatus Pharmaceuticals Inc. 4
Accession 0001209191-15-053230
CIK 0001383701operating
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:09 PM ET
Size
5.7 KB
Accession
0001209191-15-053230
Insider Transaction Report
Form 4
LACASSE LOUIS P
Director
Transactions
- Award
Stock Option (Right to Buy)
2015-06-11+15,000→ 15,000 totalExercise: $5.52Exp: 2025-06-10→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option become exercisable as the shares vest. The entire number of shares subject to this option becomes fully vested and exercisable on the first anniversary of the grant date, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
Documents
Issuer
Conatus Pharmaceuticals Inc.
CIK 0001383701
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001383701
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:09 PM ET
- Size
- 5.7 KB